Discovery, evaluation and validation of disease biomarkers through biochemical, biophysical, physicochemical and immunochemical approaches

• To validate and complement newly communicated genetic or clinical association studies by providing structure and mechanism-based insight that can establish the diagnostic and prognostic value of protein biomarkers for human diseases. (Specific projects: adaptive immune response, lipid metabolism).
• To develop biomolecular tools (e.g. peptide derivatives capable of being radiolabeled, well-characterized anti-peptide antibodies, etc.) for studying marker-molecules with diagnostic and/or therapeutic potential (e.g. neuroprotective and immunomodulating peptides, proteins related with cardiovascular diseases, etc.)